Register

Forgot your password?

Forgot your username?

ScyFIX

570 W 78TH ST # 2001
Minneapolis, MN 55317 USA
phone:phone
fax:fax
Click for website
Research Sector Medical Devices
Summary Description Micro-current Neuromodulation for Recovery of Diseased Eye Tissue

Click here for Financial Data KeywordsMicro-Current Neuromodulation/Stimulation, Macular Degeneration, Retinitis Pigmentosa, Diabetic Retinopathy, Glaucoma, CMV-Retinitis

Description

ScyFIX is developing sight-saving technologies for people suffering from degenerative eye diseases for which there are currently no cures or therapies. ScyFIX offers the only patented micro-current ne......view more

Products / Services

The ScyFIX 700 micro current neuromodulation/stimulation device facilitates increased brightness, decreased fogginess, improved visual acuity, enhanced color perception and reduction of blind spots. M......view more


Technology / Differentiation

Research suggests that the ScyFIX electrical neuromodulation/stimulation device approximates the level of electrical activity present in a healthy eye, stimulating recovery in diseased or dormant cell...view more

Market / Customers

Macular degeneration (MD) is a major cause of eyesight deterioration in older age groups, affecting millions of people. It is estimated that 5% of the world's population will develop a form of MD. Cur......view more


Competitors / Substitutes / Alternatives

Other than the ScyFIX 700, there are no device treatments or cures for Retinitis Pigmentosa and Dry Macular Degeneration...view more

Strategy

Build distribution outside the US in Europe, Asia, South America and Canada during the balance of 2009 and 2010; while awaiting US FDA approval...view more

Revenue / Funding

Owners and private individuals...view more

Status

The ScyFIX 700 is approved for use in Europe, and the regulatory requirements for Canada have been met as well. ScyFix anticipates receiving FDA approval for the use of micro-current neuromodulation/s...view more



2018-08-16-17366